Pregnant women without Zika virus symptoms who have lived in or traveled to areas with Zika transmission should receive nucleic acid testing for Zika at least once per trimester, in addition to the previously recommended immunoglobulin M testing, the Centers for Disease Control and Prevention said in an advisory today. “If positive, this may provide a more definitive diagnosis of recent Zika infection,” CDC said. “However, a negative NAT does not rule out recent infection because viral ribonucleic acid declines over time. Other diagnostic methods, such as NAT testing of amniocentesis specimens or serial ultrasounds, may provide additional information to help determine whether the IgM test results suggest a recent infection.” Recommendations for testing symptomatic pregnant women remain unchanged, the agency said.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response tomorrow will host a webinar on lessons…
Headline
Health and Human Services Acting Secretary Eric Hargan yesterday declared a public health emergency in California due to the wildfires devastating the…
Headline
The California Hospital Association and its regional partners have established a Hospital Workers’ Fire Relief Fund to help the more than 100 hospital…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
At least two hospitals evacuated patients yesterday due to the wildfires in northern California. Kaiser Permanente transported about 130 patients from Santa…
Headline
Health and Human Services Acting Secretary Don Wright, M.D., yesterday declared public health emergencies in Alabama, Florida, Louisiana and Mississippi due to…